In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Norwegian offshore services provider DOF Group has secured two new contracts in Brazil. The Skandi Logger, an anchor handling tug supply (AHTS) vessel with a bollard pull capacity of 250t, has been ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...